Organ Involvement in Patients With Grade II-IV Acute GVHD
| Stage of Malignancy . | Tacrolimus . | Cyclosporine . | P Value3-150 . |
|---|---|---|---|
| Nonadvanced | N = 27 (%) | N = 44 (%) | .07 |
| Skin only | 2 (7) | 9 (20) | |
| Skin + GI | 4 (15) | 12 (27) | |
| Skin + liver | 2 (7) | 4 (9) | |
| Skin + GI + liver | 3 (11) | 9 (20) | |
| GI only | 9 (34) | 6 (14) | |
| GI + liver | 6 (22) | 2 (5) | |
| Liver only | 1 (4) | 2 (5) | |
| Advanced disease | n = 16 (%) | n = 23 (%) | .52 |
| Skin only | 2 (13) | 4 (18) | |
| Skin + GI | 4 (25) | 6 (26) | |
| Skin + liver | 1 (6) | 1 (4) | |
| Skin + GI + liver | 8 (50) | 6 (26) | |
| GI only | 0 (0) | 4 (18) | |
| GI + liver | 1 (6) | 1 (4) | |
| Liver only | 0 (0) | 1 (4) |
| Stage of Malignancy . | Tacrolimus . | Cyclosporine . | P Value3-150 . |
|---|---|---|---|
| Nonadvanced | N = 27 (%) | N = 44 (%) | .07 |
| Skin only | 2 (7) | 9 (20) | |
| Skin + GI | 4 (15) | 12 (27) | |
| Skin + liver | 2 (7) | 4 (9) | |
| Skin + GI + liver | 3 (11) | 9 (20) | |
| GI only | 9 (34) | 6 (14) | |
| GI + liver | 6 (22) | 2 (5) | |
| Liver only | 1 (4) | 2 (5) | |
| Advanced disease | n = 16 (%) | n = 23 (%) | .52 |
| Skin only | 2 (13) | 4 (18) | |
| Skin + GI | 4 (25) | 6 (26) | |
| Skin + liver | 1 (6) | 1 (4) | |
| Skin + GI + liver | 8 (50) | 6 (26) | |
| GI only | 0 (0) | 4 (18) | |
| GI + liver | 1 (6) | 1 (4) | |
| Liver only | 0 (0) | 1 (4) |
Abbreviation: GI, gastrointestinal.
By Fisher's exact test.